わかもと製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 医薬品 | 4512/E00928 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2017/11/10 | 日証協 | 80,000株 | 0.00% | 58,001株 | +28.89% | 70,344株 | -1.40% | 17,000株 | +21.42% |
| 2017/11/02 | 日証協 | 80,000株 | +12.68% | 45,000株 | -8.16% | 71,344株 | 0.00% | 14,001株 | -36.36% |
| 2017/10/27 | 日証協 | 71,000株 | -8.16% | 49,000株 | +113.04% | 71,343株 | +31.28% | 22,000株 | +340.00% |
| 2017/10/20 | 日証協 | 77,312株 | +20.21% | 23,000株 | +109.09% | 54,343株 | -6.86% | 5,000株 | -50.00% |
| 2017/10/13 | 日証協 | 64,312株 | +8.43% | 11,000株 | -15.38% | 58,343株 | +11.46% | 10,000株 | -50.76% |
| 2017/10/06 | 日証協 | 59,312株 | -16.83% | 13,000株 | -67.50% | 52,343株 | +18.91% | 20,310株 | +915.50% |
| 2017/09/29 | 日証協 | 71,312株 | +36.32% | 40,000株 | +900.00% | 44,019株 | -42.35% | 2,000株 | -84.62% |
| 2017/09/22 | 日証協 | 52,312株 | -22.28% | 4,000株 | -94.12% | 76,352株 | -17.33% | 13,000株 | -7.15% |
| 2017/09/15 | 日証協 | 67,312株 | +62.94% | 68,000株 | +134.48% | 92,352株 | +13.52% | 14,001株 | +16.68% |
| 2017/09/08 | 日証協 | 41,312株 | -10.80% | 29,000株 | -32.56% | 81,351株 | -1.21% | 12,000株 | 0.00% |
| 2017/09/01 | 日証協 | 46,312株 | +9.45% | 43,000株 | +79.17% | 82,351株 | 0.00% | 0株 | -100.00% |
| 2017/08/25 | 日証協 | 42,312株 | +49.45% | 24,000株 | +20.00% | 82,351株 | +7.86% | 4,000株 | -75.00% |
| 2017/08/18 | 日証協 | 28,312株 | +26.89% | 20,000株 | +300.00% | 76,351株 | +4.09% | 16,000株 | +220.00% |
| 2017/08/10 | 日証協 | 22,312株 | +9.85% | 5,000株 | -44.44% | 73,351株 | -3.93% | 5,000株 | -37.50% |
| 2017/08/04 | 日証協 | 20,312株 | -22.80% | 9,000株 | -10.00% | 76,351株 | +1.33% | 8,000株 | +100.00% |
| 2017/07/28 | 日証協 | 26,312株 | +36.25% | 10,000株 | +42.86% | 75,351株 | 0.00% | 4,000株 | +33.33% |
| 2017/07/21 | 日証協 | 19,312株 | 0.00% | 7,000株 | -12.50% | 75,351株 | +2.73% | 3,000株 | +50.00% |
| 2017/07/14 | 日証協 | 19,312株 | -4.92% | 8,000株 | +33.33% | 73,352株 | +5.77% | 2,000株 | -71.43% |
| 2017/07/07 | 日証協 | 20,312株 | +10.92% | 6,000株 | -50.00% | 69,352株 | +1.46% | 7,000株 | +600.00% |
※株式分割は考慮していませんのでご注意ください。
Page Top